Late-breaking abstract: Tumor marker pattern in benign pleural effusion investigation. A case report of increased pleural CA 125

M. Kougias, G. Boulbasakos, E. Balis, V. Lazarou, G. Tatsis (Athens, Greece)

Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Session: Clinical challenges in tuberculosis
Session type: Thematic Poster Session
Number: 2710
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Kougias, G. Boulbasakos, E. Balis, V. Lazarou, G. Tatsis (Athens, Greece). Late-breaking abstract: Tumor marker pattern in benign pleural effusion investigation. A case report of increased pleural CA 125. Eur Respir J 2011; 38: Suppl. 55, 2710

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Pleurodosis through drain for malignant pleural effusion : a case control study
Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction
Year: 2021


Diagnostic approach in a patient with pleural effusion
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131
Year: 2002

Is pleural VEGF a useful parameter?
Source: Annual Congress 2007 - Pleural malignancy
Year: 2007


A prospective trial evaluating the role of mesothelin in undiagnosed pleural effusions
Source: Eur Respir J 2013; 41: 18-24
Year: 2013



Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment
Source: Eur Respir Rev 2016; 25: 472-486
Year: 2016



Recurrent pleural effusion – An unusual diagnosis: A case report
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110
Year: 2002

Tumour marker (TM) CA 19-9 in pleural fluid at patients with malignant and paramalignant pleural effusion (PE)
Source: Eur Respir J 2001; 18: Suppl. 33, 387s
Year: 2001

ERS/EACTS statement on the management of malignant pleural effusions
Source: Eur Respir J, 52 (1) 1800349; 10.1183/13993003.00349-2018
Year: 2018



ERS/EACTS statement on the management of malignant pleural effusions
Source: Guideline 2018
Year: 2018

A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Black pleural effusion as the presenting feature of lung cancer.
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018

Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

A case report: pleural fibrosarcoma with multiple masses
Source: Eur Respir J 2002; 20: Suppl. 38, 273s
Year: 2002

A case of etanercept-induced alternating pleural effusions
Source: Annual Congress 2008 - Pleural diseases and interventions
Year: 2008


An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019

Diagnostic utility of eosinophilic pleural effusion: A ten years series
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010